BlackRock Investment Management, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 29 filers reported holding CASI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$4,0000.0%3,3750.0%0.00%
Q3 2016$4,000
+33.3%
3,375
+20.4%
0.00%
Q2 2016$3,0000.0%2,8020.0%0.00%
Q1 2016$3,0000.0%2,8020.0%0.00%
Q4 2015$3,0000.0%2,8020.0%0.00%
Q3 2015$3,000
-40.0%
2,8020.0%0.00%
Q2 2015$5,0000.0%2,802
-14.5%
0.00%
Q1 2015$5,000
+25.0%
3,2760.0%0.00%
Q4 2014$4,000
-33.3%
3,2760.0%0.00%
Q3 2014$6,0003,2760.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$12,359,00022.48%
Consonance Capital Management LP 10,321,956$15,999,0001.92%
Wellington Shields & Co., LLC 1,832,769$2,841,0000.94%
Wellington Shields Capital Management, LLC 2,258,264$3,500,0000.42%
Ghost Tree Capital, LLC 650,000$1,008,0000.28%
Ikarian Capital, LLC 1,268,154$1,966,0000.16%
Tibra Equities Europe Ltd 216,300$335,0000.10%
1492 Capital Management LLC 79,743$124,0000.06%
FEDERATED HERMES, INC. 10,150,000$15,733,0000.03%
Sterneck Capital Management, LLC 40,000$47,0000.03%
View complete list of CASI PHARMACEUTICALS INC shareholders